Evidence map›Paper›PMID 38031776›Full record

ReviewCurrent medicinal chemistry2024

Porphyrinuria in Autism Spectrum Disorder: A Review.

Geir Bjørklund, Yuliya Semenova, Afaf El-Ansary, Laila Youssef Al-Ayadhi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Geir BjørklundDepartment of Research, Council for Nutritional and Environmental Medicine, Mo i Rana, Norway.
Yuliya SemenovaSchool of Medicine, Nazarbayev University, Astana, Kazakhstan.
Afaf El-AnsaryAutism Center, Lotus Holistic Alternative Medical Center, Abu Dhabi, United Arab Emirates.
Laila Youssef Al-AyadhiDepartment of Physiology, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.
King Saud University · SANazarbayev University · KZThe Research Council of Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous studies demonstrated that the number of children with autism spectrum disorder (ASD) has increased remarkably in the past decade. A portion of ASD etiology, however, is attributed to environmental issues and genetic disorders. We highlighted a scoping review to principally evaluate the current information on mercury exposure in ASD children and to reveal knowledge gaps. Elevated porphyrins concentration in the urinary system related to mercury exposure, such as precoproporphyrin (prcP), coproporphyrin (cP), and pentacarboxyporphyrin (5cxP), was shown in comparison with controls. Moreover, high levels of urinary porphyrins have been elevated in response to heavy metal exposure. The related pattern (increased prcP, cP, and 5cxP) with Hg exposure may be used as biomarkers in the characteristics of ASD symptoms. However, this review highlighted the data gaps because the control groups were not genderand age-matched for ASD children.

Indexed as

Autism Spectrum DisorderPorphyrinsBiomarkersChildHumansMercuryBiomarkersMercuryPorphyrinsAutism spectrum disorderbiomarkers.environmental factorsgeneticsmercury exposureurinary porphyrins

Identifiers

PMID38031776
OpenAlexW4389180573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.